{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
INN:libivirumab [INN]
Source URL:
Class:
PROTEIN
Class:
PROTEIN
Status:
Investigational
Source:
INN:metelimumab [INN]
Source URL:
Class:
PROTEIN
Status:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01963598: Phase 2 Interventional Completed Sarcopenia
(2013)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02453087: Phase 1 Interventional Completed Non-Hodgkin's Lymphoma
(2015)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01918254: Phase 1 Interventional Completed Breast Cancer
(2013)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00004215: Phase 2 Interventional Completed Anemia
(1999)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00041652: Phase 1/Phase 2 Interventional Completed Colorectal Cancer
(2000)
Source URL:
Class:
PROTEIN